ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,689.99
1.27%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Amylyx Pharmaceuticals Inc (AMLX)

  7. Amylyx Pharmaceuticals Inc (AMLX) 뉴스

AMLX Amylyx Pharmaceuticals Inc

2.0115
0.0115 (0.57%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Amylyx Pharmaceuticals Inc AMLX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.0115 0.57% 2.0115 13:00:03
개장가 저가 고가 종가 전일 종가
2.05 2.00 2.13 2.03 2.00
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202422:00BWAmylyx Pharmaceuticals to Report First Quarter 2024..
10/04/202422:00BWAmylyx Pharmaceuticals Announces Interim Data From Ongoing..
09/04/202418:45PRNUSThe Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc...
08/04/202422:00BWAmylyx Pharmaceuticals to Host Virtual Webcast to Discuss..
05/04/202418:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
04/04/202420:00BWAmylyx Pharmaceuticals Announces Formal Intention to Remove..
02/04/202418:45PRNUSThe Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc...
29/03/202418:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
26/03/202418:45PRNUSShareholders of Amylyx Pharmaceuticals, Inc. Should Contact..
25/03/202421:00PRNUSINVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX)..
22/03/202418:45PRNUSThe Gross Law Firm Notifies Shareholders of Amylyx..
19/03/202418:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
14/03/202422:00BWAmylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,..
14/03/202418:50PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
11/03/202421:44EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/03/202418:50PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
08/03/202421:10EDGAR2Form 8-K - Current report
08/03/202421:00BWAmylyx Pharmaceuticals Announces Topline Results From Global..
08/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202419:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
29/02/202408:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202408:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/02/202419:45PRNUSAMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx..
24/02/202406:05BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
23/02/202406:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/02/202422:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/02/202421:08EDGAR2Form 8-K - Current report
22/02/202421:00BWAmylyx Pharmaceuticals Reports Fourth Quarter and Full Year..
22/02/202419:45PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
16/02/202406:05BWAmylyx Pharmaceuticals to Report Fourth Quarter and Full..
15/02/202423:00BWAmylyx Pharmaceuticals to Present Updates on its AMX0114 and..
15/02/202419:00PRNUSLost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class..
08/02/202423:00BWAmylyx Pharmaceuticals Announces Completion of Enrollment in..
12/01/202407:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202323:00BWAmylyx Pharmaceuticals Announces First Participant Dosed in..
20/12/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202321:00EDGAR2Form 8-K - Current report
04/12/202323:00BWAmylyx Pharmaceuticals Announces Publication of Data Showing..
30/11/202307:15BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
28/11/202321:00BWAmylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as..
27/11/202323:00BWRELYVRIO® and AMX0114 Data to be Presented at 34th..
21/11/202323:00BWAmylyx Pharmaceuticals to Participate at the 6th Annual..
21/11/202310:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202321:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

최근 히스토리

NASDAQ
AMLX
Amylyx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유